Form F-4 - Registration of securities, foreign private issuers, business combinations:
SEC Accession No. 0001104659-25-100534
Filing Date
2025-10-20
Accepted
2025-10-17 21:52:57
Documents
23

Document Format Files

Seq Description Document Type Size
1 F-4 tm2528979d1_f4.htm F-4 1509232
2 EXHIBIT 5.1 tm2528979d1_ex5-1.htm EX-5.1 14474
3 EXHIBIT 23.1 tm2528979d1_ex23-1.htm EX-23.1 3090
4 EX-FILING FEES tm2528979d1_exfilingfee.htm   iXBRL EX-FILING FEES 25272
5 GRAPHIC tm2528979d1_ex5-1img001.jpg GRAPHIC 3065
6 GRAPHIC tm2528979d1_f4img002.jpg GRAPHIC 198851
7 GRAPHIC tm2528979d1_f4img003.jpg GRAPHIC 78625
8 GRAPHIC tm2528979d1_f4img004.jpg GRAPHIC 106553
9 GRAPHIC tm2528979d1_f4img005.jpg GRAPHIC 87016
10 GRAPHIC tm2528979d1_f4img006.jpg GRAPHIC 53099
11 GRAPHIC tm2528979d1_f4img007.jpg GRAPHIC 162490
12 GRAPHIC tm2528979d1_f4sp4img01.jpg GRAPHIC 7043
13 GRAPHIC tm2528979d1_prosimg01.jpg GRAPHIC 4277
  Complete submission text file 0001104659-25-100534.txt   2614845

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT tm2528979d1_exfilingfee_htm.xml XML 4645
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-4 | Act: 33 | File No.: 333-290954 | Film No.: 251402218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)